Literature DB >> 26125327

Structure-Affinity Relationships (SARs) and Structure-Kinetics Relationships (SKRs) of Kv11.1 Blockers.

Zhiyi Yu1, Jacobus P D van Veldhoven1, Julien Louvel1, Ingrid M E 't Hart1, Martin B Rook, Marcel A G van der Heyden, Laura H Heitman1, Adriaan P IJzerman1.   

Abstract

Kv11.1 (hERG) blockers with comparable potencies but different binding kinetics might display divergent pro-arrhythmic risks. In the present study, we explored structure-kinetics relationships in four series of Kv11.1 blockers next to their structure-affinity relationships. We learned that despite dramatic differences in affinities and association rates, there were hardly any variations in the dissociation rate constants of these molecules with residence times (RTs) of a few minutes only. Hence, we synthesized 16 novel molecules, in particular in the pyridinium class of compounds, to further address this peculiar phenomenon. We found molecules with very short RTs (e.g., 0.34 min for 37) and much longer RTs (e.g., 105 min for 38). This enabled us to construct a k on-k off-KD kinetic map for all compounds and subsequently divide the map into four provisional quadrants, providing a possible framework for a further and more precise categorization of Kv11.1 blockers. Additionally, two representative compounds (21 and 38) were tested in patch clamp assays, and their RTs were linked to their functional IC50 values. Our findings strongly suggest the importance of the simultaneous study of ligand affinities and kinetic parameters, which may help to explain and predict Kv11.1-mediated cardiotoxicity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26125327     DOI: 10.1021/acs.jmedchem.5b00518

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  A binding kinetics study of human adenosine A3 receptor agonists.

Authors:  Lizi Xia; Athina Kyrizaki; Dilip K Tosh; Tirsa T van Duijl; Jacomina Cornelia Roorda; Kenneth A Jacobson; Adriaan P IJzerman; Laura H Heitman
Journal:  Biochem Pharmacol       Date:  2018-01-03       Impact factor: 5.858

2.  A structure-kinetic relationship study using matched molecular pair analysis.

Authors:  Doris A Schuetz; Lars Richter; Riccardo Martini; Gerhard F Ecker
Journal:  RSC Med Chem       Date:  2020-09-21

3.  Rollover Cyclometalation vs Nitrogen Coordination in Tetrapyridyl Anticancer Gold(III) Complexes: Effect on Protein Interaction and Toxicity.

Authors:  Xue-Quan Zhou; Imma Carbo-Bague; Maxime A Siegler; Jonathan Hilgendorf; Uttara Basu; Ingo Ott; Rongfang Liu; Liyan Zhang; Vadde Ramu; Adriaan P IJzerman; Sylvestre Bonnet
Journal:  JACS Au       Date:  2021-03-16

4.  Structure-Affinity Relationships and Structure-Kinetics Relationships of Pyrido[2,1-f]purine-2,4-dione Derivatives as Human Adenosine A3 Receptor Antagonists.

Authors:  Lizi Xia; Wessel A C Burger; Jacobus P D van Veldhoven; Boaz J Kuiper; Tirsa T van Duijl; Eelke B Lenselink; Ellen Paasman; Laura H Heitman; Adriaan P IJzerman
Journal:  J Med Chem       Date:  2017-08-30       Impact factor: 7.446

5.  A novel CCR2 antagonist inhibits atherogenesis in apoE deficient mice by achieving high receptor occupancy.

Authors:  Ilze Bot; Natalia V Ortiz Zacarías; Wilhelmus E A de Witte; Henk de Vries; Peter J van Santbrink; Daniël van der Velden; Mara J Kröner; Dirk-Jan van der Berg; Dean Stamos; Elizabeth C M de Lange; Johan Kuiper; Adriaan P IJzerman; Laura H Heitman
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.